Popular Stop-Smoking Drugs to Carry Mental Health Risk Warnings

The FDA said it will immediately require boxed warnings about the risk of serious neuropsychiatric symptoms on the packaging of two popular smoking cessation drugs, — varenicline (Chantix) and bupropion (Zyban, Wellbutrin, and generics).

First I read this from KevinMd site. Then from the medpage site. See the link below. To think that these drugs is said has been very effective in helping smokers to quit. I should go to read about their mechanisms of action but i recall the importance of Nucleus acumbens, situated at the base of the bran, in developing reward.

Popular Stop-Smoking Drugs to Carry Mental Health Risk Warnings

Shared via AddThis